Monday, 16 March 2020
Vetgenomics has obtained an American grant of a patent in collaboration with the ICN2
The patent, a method to detect target DNA sequences, has been developed with the Nanobioelectronics and Biosensors Group, led by ICREA Prof. Arben Merkoçi.
Vetgenomics is a company devoted to diagnosis and research in "One Health", with expertise in genomics, pathogens and microbiome. They have obtained the American grant of the patent "Methods for detecting target DNA sequences" based on electrochemical detection of target DNA sequences. This patent has been developed in collaboration with the ICN2 Nanobioelectronics and Biosensors group, led by ICREA Prof. Arben Merkoçi, on behalf of the European project POC4PETS (FP7-BSG-SME) aimed at providing Point-of-Care technologies for the detection of pathogens in pets.
Infectious diseases are one of the major global threats: they can have implications in human health and pets play an important role as disease reservoirs. In this sense, the development of an inexpensive and reliable system that allows the direct detection of the pathogen in the same care centre, or where the outbreak is occurring, has great potential.
The invention relates a novel methodology for detecting target DNA sequences in a fully integrated way that combines isothermal amplification with a sensitive electrochemical detection based on the use of gold nanoparticles and magnetic beads.
More information: